mutant p53 peptide pulsed dendritic cell vaccine
Term · Oncology and biomedicine · MLC-T-ONC-015369
A cancer vaccine consisting of autologous dendritic cells which have been pulsed with a mutant p53 peptide. Vaccination with mutant p53 peptide pulsed dendritic cells may stimulate the host immune system to mount a cytotoxic T lymphocyte (CTL) response against tumor cells expressing mutant p53, resulting in tumor cell lysis. Many tumor cells overexpress mutant p53 proteins, resulting in the loss of apoptosis regulation and abnormal cell proliferation.
| Identifier | MLC-T-ONC-015369 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | p53 DEN |
| Synonyms | mutant p53 peptide pulsed DC vaccine |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-015369",
"term": "mutant p53 peptide pulsed dendritic cell vaccine",
"field": "Oncology and biomedicine",
"definition": "A cancer vaccine consisting of autologous dendritic cells which have been pulsed with a mutant p53 peptide. Vaccination with mutant p53 peptide pulsed dendritic cells may stimulate the host immune system to mount a cytotoxic T lymphocyte (CTL) response against tumor cells expressing mutant p53, resulting in tumor cell lysis. Many tumor cells overexpress mutant p53 proteins, resulting in the loss of apoptosis regulation and abnormal cell proliferation.",
"abbreviation": "p53 DEN",
"synonyms": [
"mutant p53 peptide pulsed DC vaccine"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/mutant-p53-peptide-pulsed-dendritic-cell-vaccine/"
}
Record 11,459 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.